Applications of Nanotechnology in Diabetes - A Review

Authors

  • A. D. Suryawanshi  Department of Physics, B. J. College, Ale, Pune, Maharashtra, India
  • V. B. Sanap  Department of Physics Y.C.College, Sillod, Aurangabad, Maharashtra, India
  • D. D. Suryawanshi  Department of Chemistry, S.C.S. College, Omerga, Osmanabad, Maharashtra, India
  • B. H. Pawar  Ex.Head, Department of Physics S.G.B. Amravati University, Amravati, Maharashtra, India

Keywords:

Nanotechnology, Diabetes, Nanoparticles, Nanomedicine, Nanospheres

Abstract

Nanotechnology is an advanced scientific technique that provides more accurate and timely medical information for diagnosing disease. Diabetes mellitus (DM) is a commonly seen chronic disease, which seriously threatens the health of human beings. About 150 million people suffer from diabetes in the world and it has been predicted that this number will be doubled within 15 years. Nanotechnology is a focal point in diabetes research, where nanoparticles in particular are showing great promise in improving the treatment and management of the disease. Nanotechnology can now offers new implantable or wearable sensing technologies that provide continuous and extremely accurate medical information. The purpose of this is to throw more light on the recent advances and impact of nanotechnology on biomedical sciences to cure diabetes. Nano medicine, the application of nanotechnology to medicine, has already offered some new solutions, and many pharmaceutical companies are trying to develop targeted drug delivery using nanotechnology and already existing drugs. Nanotechnology offers some new solutions in treating diabetes mellitus. This review concluded that nanotechnology will be effective therapy in diabetes.

References

  1. Wild S, Roglic G, et al. "Global prevalence of diabetes: estimates for 2000 and projections for 2030". Diabetes Care 27 (5): 2004; 1047–53.
  2. Agabegi D Elizabeth; Agabegi, Steven S. Step-Up to Medicine (Step-Up Series). Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 2008; 0-7817-7153-6.
  3. Lambert P. "What is Type 1 Diabetes?”. Medicine 30: 2002; 1–5.
  4. Microphysiometer using multiwall carbon nanotubes enable constant realtime monitoring of microliters of insulin [electronic resource] [accessed 2008 Apr 18]. Available from: URL: http://nextbigfuture.com/2008/04/microphysiometer-using-multiwall carbon.html
  5. Insulin Nanodrug under Development; [electronic resource] [accessed 2007 Oct 02]. Available from: URL: http://thefutureofthings.com/news/1014/insulin-nanodrug-under- development.html
  6. Liang H F, Hong M H, Ho R M, Chung C K, Lin Y H, Chen C H and Sung H W. Novel method using a temperature-sensitive polymer (methylcellulose) to thermally gel aqueous alginate as a pH-sensitive hydrogel Biomacromolecules 5, 1917– 25(2004).
  7. Smyth S and Heron A. Diabetes and obesity: the twin epidemics Nat. Med. 12, 75– 80 (2006)
  8. Krauland A H, Guggi D and Bernkop-Schn¨urch A . Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats J. Control. Release 95, 547– 55(2004)
  9. Borchard G, Lueßen H L, de Boer A G, Verhoef J C, Lehr C M and Junginger H E. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro J. Control. Release 39, 131– 8(1996).
  10. Kotz´e A F, Lueßen H L, de Leeuw B J, de Boer (A)B G, Verhoef J C and Junginger H E . Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2) J. Control. Release 51, 35– 46(1998). 225
  11. Lamprecht A, Koenig P, Ubrich N, Maincent P and Neumann D. Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells Nanotechnology 17, 3673– 80(2006).
  12. Ward P D, Tippin T K and Thakker D R . Enhancing paracellular permeability by modulating epithelial tight junctions Pharm. Sci. Technol. Today 3, 346– 58(2000).
  13. Ramadas M, Paul W, Dileep K J, Anitha Y and Sharma C P. Lipoinsulin encapsulated alginate-chitosan capsules: Intestinal delivery in diabetic rats J. Microencapsul 17, 405– 11 (2000).
  14. Agnihotri S A, Mallikarjuna N N and Aminabhavi T M. Recent advances on chitosan-based micro-and nanoparticles in drug delivery J. Control. Release 100,5– 28(2004).
  15. Gerardo P. Carino, Edith Mathiowitz. Oral insulin delivery; Advanced Drug Delivery Reviews 35,249–257(1999).
  16. Hanazaki K, Nose Y, Brunicardi FCh. Artificial endocrine pancreas. J Am Coll Surg [electronic resource] [accessed 2006 Jan 20]. Available from: URL: http://www.sciencedirect.com/science?_ob=Article
  17. Freitas RA. Current status of Nanomedicine and Medical Nanorobotics [electronic resource] [accessed 2006 Jan 20]. Available from: URL:http://www.nanomedicine.com/Papers/NMRevMar05.pdf
  18. Insulin Nanopump for Accurate Drug Delivery.[electronic resource][accessed 2008Aug 15]. Available from: http://thefutureofthings.com/news/1286/insulin-nanopump-for-accurate-drug-delivery.html.

International Journal of Scientific Research in Science and Technology

Downloads

Published

2021-04-15

Issue

Volume 9, Issue 4, March-April-2021

Section

Research Articles

License

Copyright (c) IJSRST

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
A. D. Suryawanshi, V. B. Sanap, D. D. Suryawanshi, B. H. Pawar "Applications of Nanotechnology in Diabetes - A Review" International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011,Volume 9, Issue 4, pp.95-99, March-April-2021.